Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $20,385 | 1,207 | 98.7% |
| Education | $277.36 | 18 | 1.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,352 | 141 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $2,047 | 111 | $0 (2024) |
| Lilly USA, LLC | $1,644 | 87 | $0 (2024) |
| PFIZER INC. | $1,629 | 83 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,609 | 77 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,142 | 79 | $0 (2024) |
| Amgen Inc. | $1,134 | 78 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,105 | 97 | $0 (2024) |
| Allergan, Inc. | $997.22 | 70 | $0 (2020) |
| Novo Nordisk Inc | $704.74 | 47 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,067 | 108 | ABBVIE INC. ($280.31) |
| 2023 | $1,847 | 103 | Lilly USA, LLC ($382.67) |
| 2022 | $2,056 | 94 | ABBVIE INC. ($495.78) |
| 2021 | $2,955 | 166 | AbbVie Inc. ($769.85) |
| 2020 | $3,378 | 193 | AstraZeneca Pharmaceuticals LP ($509.25) |
| 2019 | $2,294 | 138 | Boehringer Ingelheim Pharmaceuticals, Inc. ($376.56) |
| 2018 | $2,909 | 197 | Boehringer Ingelheim Pharmaceuticals, Inc. ($334.21) |
| 2017 | $3,154 | 226 | Allergan Inc. ($377.24) |
All Payment Transactions
1,225 individual payment records from CMS Open Payments — Page 1 of 49
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $10.14 | General |
| Category: DIABETES | ||||||
| 12/12/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $12.70 | General |
| Category: NEUROSCIENCE | ||||||
| 12/10/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $18.56 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 12/06/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $32.92 | General |
| Category: Neuroscience | ||||||
| 11/22/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $32.99 | General |
| Category: VACCINES | ||||||
| 11/22/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $11.88 | General |
| Category: DIABETES | ||||||
| 11/11/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $10.17 | General |
| Category: DIABETES | ||||||
| 11/06/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $8.95 | General |
| Category: Inflammation | ||||||
| 11/01/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $13.26 | General |
| Category: Oncology | ||||||
| 10/29/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $27.22 | General |
| Category: Diabetes | ||||||
| 10/29/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $26.40 | General |
| Category: Diabetes | ||||||
| 10/25/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $22.15 | General |
| Category: Diabetes | ||||||
| 10/25/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $9.06 | General |
| Category: DIABETES | ||||||
| 10/21/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $25.60 | General |
| Category: PSYCHIATRY | ||||||
| 10/17/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $28.73 | General |
| Category: Diabetes Care | ||||||
| 10/11/2024 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Food and Beverage | In-kind items and services | $15.26 | General |
| Category: Neurology | ||||||
| 10/10/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $10.60 | General |
| Category: NEUROSCIENCE | ||||||
| 10/09/2024 | AIMMUNE THERAPEUTICS, INC. | VOWST (Biological) | Food and Beverage | In-kind items and services | $29.60 | General |
| Category: GI | ||||||
| 10/07/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $22.19 | General |
| Category: ANTIBIOTIC | ||||||
| 10/03/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $10.53 | General |
| Category: Inflammation | ||||||
| 09/27/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $10.27 | General |
| Category: DIABETES | ||||||
| 09/19/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $9.24 | General |
| Category: Inflammation | ||||||
| 09/09/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $18.57 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 09/06/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $20.76 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/05/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $7.79 | General |
| Category: Cardiology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 27 | 6,151 | 11,102 | $1.2M | $739,228 |
| 2022 | 26 | 5,823 | 10,842 | $1.2M | $720,992 |
| 2021 | 24 | 5,254 | 10,131 | $1.1M | $667,583 |
| 2020 | 27 | 5,837 | 10,586 | $1.0M | $637,358 |
All Medicare Procedures & Services
112 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 1,281 | 4,682 | $562,797 | $310,571 | 55.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 1,080 | 1,080 | $205,055 | $145,682 | 71.0% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Office | 2023 | 314 | 1,299 | $155,880 | $72,795 | 46.7% |
| 99305 | Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes | Office | 2023 | 323 | 382 | $70,670 | $38,359 | 54.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 280 | 320 | $44,800 | $30,617 | 68.3% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 104 | 104 | $29,640 | $29,005 | 97.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 637 | 644 | $20,750 | $20,081 | 96.8% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 228 | 228 | $15,890 | $15,572 | 98.0% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 558 | 558 | $11,484 | $10,945 | 95.3% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 44 | 48 | $11,541 | $9,238 | 80.0% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 46 | 50 | $11,000 | $8,479 | 77.1% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 42 | 42 | $8,000 | $7,234 | 90.4% |
| 90756 | Influenza vaccine, quadrivalent derived from cell cultures | Office | 2023 | 219 | 219 | $7,650 | $6,940 | 90.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 63 | 63 | $12,625 | $6,591 | 52.2% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 95 | 110 | $9,900 | $4,781 | 48.3% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 208 | 211 | $7,380 | $4,610 | 62.5% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 113 | 113 | $3,623 | $3,515 | 97.0% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 20 | 41 | $4,920 | $2,447 | 49.7% |
| 99305 | Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes | Facility | 2023 | 19 | 20 | $3,700 | $2,184 | 59.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 155 | 168 | $13,440 | $1,919 | 14.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 17 | 17 | $3,400 | $1,799 | 52.9% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2023 | 20 | 48 | $3,600 | $1,637 | 45.5% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2023 | 11 | 11 | $1,490 | $1,314 | 88.2% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 13 | 13 | $1,935 | $1,141 | 59.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 81 | 101 | $3,302 | $1,085 | 32.9% |
About Dr. Than Aung, MD
Dr. Than Aung, MD is a Internal Medicine healthcare provider based in Redding, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1578504841.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Than Aung, MD has received a total of $20,662 in payments from pharmaceutical and medical device companies, with $2,067 received in 2024. These payments were reported across 1,225 transactions from 65 companies. The most common payment nature is "Food and Beverage" ($20,385).
As a Medicare-enrolled provider, Aung has provided services to 23,065 Medicare beneficiaries, totaling 42,661 services with total Medicare billing of $2.8M. Data is available for 4 years (2020–2023), covering 112 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Redding, CA
- Active Since 06/09/2006
- Last Updated 07/18/2007
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1578504841
Products in Payments
- JARDIANCE (Drug) $2,156
- FARXIGA (Drug) $1,121
- UBRELVY (Drug) $878.45
- XARELTO (Drug) $743.45
- VRAYLAR (Drug) $718.90
- Vascepa (Drug) $607.33
- TRELEGY ELLIPTA (Drug) $491.71
- Otezla (Drug) $475.76
- JANUVIA (Drug) $469.33
- NURTEC ODT (Drug) $433.77
- SPIRIVA RESPIMAT (Drug) $421.39
- CREON (Drug) $395.82
- Aimovig (Biological) $389.36
- LINZESS (Drug) $387.04
- Amitiza (Drug) $365.83
- Ozempic (Drug) $341.69
- CHANTIX (Drug) $323.00
- PREVNAR 20 (Biological) $309.07
- ELIQUIS (Drug) $284.38
- Victoza (Drug) $275.82
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Redding
Dr. Javed Nasir, Md, MD
Internal Medicine — Payments: $17,178
Shirish Mahajan, Md, MD
Internal Medicine — Payments: $13,790
Robert Coronado, M.d, M.D
Internal Medicine — Payments: $9,294
Nicholas Germano, Do, DO
Internal Medicine — Payments: $3,385
Olivia Mansilla, Md, MD
Internal Medicine — Payments: $3,244
Dr. Louis Bernstein, M.d, M.D
Internal Medicine — Payments: $3,040